If you notice your dog has skin lesions, is scratching more than usual, or has a bad odor, they might be dealing with a ...

Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) that causes gastrointestinal symptoms. But it may also lead to conditions that cause joint pain, such as arthritis. Research suggests ...

Although Shih Tzus are seen for quite a few skin diseases, they’re so small that they’re easy to bathe and groom. Shihpoos ...

Intellia’s stock fell 23% after one patient in its Phase III MAGNITUDE trial developed severe liver toxicity that later ...

In a report released yesterday, Andreas Argyrides from Oppenheimer maintained a Buy rating on InflaRx (IFRX – Research Report), with a price target of $3.00. The company’s sha ...

InflaRx (IFRX) stock plummeted on Wednesday after the clinical-stage biopharmaceutical company announced a halt to its Phase 3 trial of vilobelimab to treat pyoderma gangrenosum. The company did so at ...

PetHelpful. Q: "My dog has red, irritated skin under his nostrils and started getting scabs under his mouth in the winter, ...

Backers of Jena, Germany-based Inflarx NV have turned their attention to the rest of the pipeline after the stock-jolting news from an independent data monitoring committee (DMC) responsible for the ...

InflaRx ends its Phase 3 trial of vilobelimab in pyoderma gangrenosum and shifts focus to INF904 amid efforts to extend its ...

German drug developer InflaRx (Nasdaq: IFRX) saw its US-traded shares plunge 55% to $0.82 in pre-market activity today, as it ...

Treatment of PG is currently limited to immune-suppressing drugs and antibiotics to treat complicating infections, and, in ...

InflaRx’s vilobelimab met the bar for futility in a Phase III trial for the rare skin disease pyoderma gangrenosum.